Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 418-000-8 | CAS number: 163062-28-0 BLEU REN 20
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Qualifier:
- according to guideline
- Guideline:
- other: International Workshop on Standardization of Genotoxicity Test Procedures, Melbourne, Australia, 1993
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 6,13-dichloro-3,10-bis-{2-[4-fluoro-6-(2-sulfo-phenylamino)-1,3,5-triazin-2-ylamino]-propylamino}-benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium, sodium salt.
- EC Number:
- 418-000-8
- EC Name:
- 6,13-dichloro-3,10-bis-{2-[4-fluoro-6-(2-sulfo-phenylamino)-1,3,5-triazin-2-ylamino]-propylamino}-benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium, sodium salt.
- Cas Number:
- 163062-28-0
- Molecular formula:
- CAS formula: C42 H34 Cl2F2 N14 O14 S4 .xLi. xNa
- IUPAC Name:
- dilithium(1+) disodium 6,13-dichloro-3,10-bis({[2-({4-fluoro-6-[(2-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)propyl]amino})-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
- Details on test material:
- - Name of test material (as cited in study report): FAT 40529/A
- Batch number: P1/95
- Storage: Room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Italia S.p.A., (Calco, Como)
- Age at study initiation: 5 to 6 weeks
- Weight at study initiation: males: 24-33g, females 20-26g
- Fasting period before study: overnight
- Housing: 5 animals/cage, by sexes, in clear ploycarbonate cages measuring 35.5x23.5x19 cm with a stainless steel mesh lid and floor (Type 2b: Techniplast). Each cage helds absorbent bedding which is inspected daily and changed as necessary.
- Diet (e.g. ad libitum): Altromin MT diet, ad libitum
- Water (e.g. ad libitum): drinking water, ad libitum
- Acclimation period: not specified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hours light/dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: 0.5% carboxymethylcellulose
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The vehicle, 0.5% carboxyme.thylcellulose, was prepared immediately before use in injectable grade sterile distilled water obtained from Laboratori Don Baxier S.p.A., TriestQ.
A solution of Mitomycin-C in 0.5% carboxymethylcellulose was prepared immediately before use, and served as a positive control
DIET PREPARATION: not specified - Frequency of treatment:
- Single treatment
- Post exposure period:
- 24 and 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000, 2000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5/sex/treatment group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin-C at 3 mg/kg bw
Examinations
- Tissues and cell types examined:
- Normochromatic and polychromatic erythrocytes.
- Details of tissue and slide preparation:
- Sacrifice and slide preparation: Groups of 5 male and 5 female animals were sacrificed 24 and 48 hours after the commencement of treatment. The femurs were removed and bone marrow cells obtained by flushing with foetal calf serum. The cells were centrifuged and a concentrated suspension prepared to make smears on slides. These slides were air-dried overnight and then stained with May-Gruenwald and Giemsa, and mounted with Eukitt. Three slides were made from each animal.
Slide evaluation: The slides were randomly coded by a person not involved in the subsequent microscope scoring. The slides were examined under low power (x 16) and one slide from each animal was selected according to staining and quality of smears. At least one thousand PCE's were examined at high power (x 100) for the presence or absence of micronuclei. At the same time the numbers of normal and micronucleated normochromatic erythrocytes were also recorded. - Evaluation criteria:
- The test substance is considered to induce micronuclei if a statistically significant increase in the micronucleus incidence in polychromatic erythrocytes (at P<0.05) is observed in any treatment group, in the pooled data for both sexes, or for either sex considered separately.
- Statistics:
- Only counts obtained from polychromatic cells were subjected to statistical analysis. Using the original observations (and not the micronucleus frequencies per 1000 cells), a modified Chi-squared calculation was employed to compare treated and control groups. The degree of heterogenity within each group was first calculated and where this was significant it was taken into account in the comparison between groups. Variance ratios or Chi-squared values are taken to show the significance of any difference between each treated group and the controls.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- A slight increases in the ratio of NCE's to PCE's over the control value was observed at the 48 hour sampling time.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY:
A preliminary dose-range screen was carried out, in which groups of two male and two female animals were dosed once by oral route with FAT 40529/A at 2000, 1000 and 500 mg/kg. Following treatment, no clinical signs were observed at any dose-level. On the basis of these results, 2000 mg/kg was selected as the highest dose-level for the micronucleus test.
RESULTS OF DEFINITIVE STUDY:
- Analysis by treatment groups: Following treatment with FAT 40529/A, no statistically significant increases in the incidences of micronucleated PCE's over the control values were observed at any sampling time.
- Analysis by sex: No statistically significant increases in the incidence of micronucleated PCE's over the control values were observed at any dose-level at any sampling time for both sexes considered separately. Significantly lower incidences (p<0.05) of micronucleated cells were observed in the female group at the 48 hour sampling time at the high and intermediate dose-levels. A statistically significant difference in response was observed between male and female animals from the high dose group at the 48 hour sampling time.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test substance did not induce micronuclei in the polychromatic erythrocytes of treated mice. - Executive summary:
In a GLP-compliant micronucleus test, performed according to OECD guideline 474, Swiss CD-1 mice (5/sex/treatment group) were treated once by oral gavage with the test substance (0, 500, 1000, 2000 mg/kg bw) dissolved in 0.5% carboxymethylcellulose followed by a 24 and 48 hours post exposure period. Following treatment with the test substance, no marked increases in the incidences of micronucleated polychromatic erythrocytes (PCE’s) were observed for combined sexes at any sampling time. Following treatment with the test substance slight increases in the ratio of normochromatic erythrocytes's to PCE's over the control value were observed at the 48 hour sampling time indicating that the test substance exerted a mild toxic effect on bone marrow erythropoietic cells. In conclusion, the test substance is not considered to be mutagenic in the micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.